Inventor · disambiguated record
Peter Bohlen
Also filed as: BOEHLEN PETER · BOHLEN PETER
32 granted patents·4 pending applications·1,312 citations·filing 1980–2011
98Inventor score
Files withAMERICAN CYANAMID CO17SALK INST FOR BIOLOGICAL STUDI11IMCLONE SYSTEMS INC4IMCLONE LLC1WU YAN1
Top patents by PatentIndex Score
36 records- 0194US5155214ABasic fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1990·Granted Oct 13, 1992·138 cites·3 claims
- 0292US7972596B2Antibodies against vascular endothelial growth factor receptor-1IMCLONE LLC·Filed 2005·Granted Jul 5, 2011·23 cites·6 claims
- 0392US6010999AStabilization of fibroblast growth factors by modification of cysteine residuesAMERICAN CYANAMID CO·Filed 1995·Granted Jan 4, 2000·97 cites·6 claims
- 0492US5843925AMethods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growthAMERICAN CYANAMID CO·Filed 1994·Granted Dec 1, 1998·117 cites·16 claims
- 0591US5310883AChimeric fibroblast growth factorsAMERICAN CYANAMID CO·Filed 1991·Granted May 10, 1994·77 cites·3 claims
- 0691US4316891AExtended N-terminal somatostatinSALK INST FOR BIOLOGICAL STUDI·Filed 1980·Granted Feb 23, 1982·104 cites·6 claims
- 0786US5574026AMethods for inhibiting angiogenesis proliferation of endothelial or tumor cells and tumor growthAMERICAN CYANAMID CO·Filed 1994·Granted Nov 12, 1996·81 cites·6 claims
- 0886US5302702AChimeric fibroblast growth factorsAMERICAN CYANAMID CO·Filed 1993·Granted Apr 12, 1994·55 cites·11 claims
- 0986US4956455ABovine fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1985·Granted Sep 11, 1990·56 cites·7 claims
- 1085US5491220ASurface loop structural analogues of fibroblast growth factorsYEDA RES & DEV·Filed 1994·Granted Feb 13, 1996·71 cites·9 claims
- 1185US4785079AIsolation of fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1986·Granted Nov 15, 1988·55 cites·13 claims
- 1278US5951972AStabilization of somatotropins and other proteins by modification of cysteine residuesAMERICAN CYANAMID CO·Filed 1995·Granted Sep 14, 1999·30 cites·17 claims
- 1378US5387673AActive fragments of fibroblast growth factorAMERICAN CYANAMID CO·Filed 1993·Granted Feb 7, 1995·44 cites·6 claims
- 1478US5371206ADNA encoding chimeric fibroblast growth factorsAMERICAN CYANAMID CO·Filed 1994·Granted Dec 6, 1994·27 cites·16 claims
- 1578US4517181AMammalian PGRFSALK INST FOR BIOLOGICAL STUDI·Filed 1982·Granted May 14, 1985·31 cites·20 claims
- 1676US5856315AMethods for inhibiting proliferation of tumor cells and tumor growthAMERICAN CYANAMID CO·Filed 1998·Granted Jan 5, 1999·39 cites·6 claims
- 1771US4610976APorcine GRFSALK INST FOR BIOLOGICAL STUDI·Filed 1983·Granted Sep 9, 1986·24 cites·10 claims
- 1870US8143025B2Antibodies against vascular endothelial growth factor receptor-1WU YAN·Filed 2011·Granted Mar 27, 2012·1 cites·5 claims
- 1970US5567693AMethod for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growthAMERICAN CYANAMID CO·Filed 1994·Granted Oct 22, 1996·37 cites·6 claims
- 2070US4585756ABovine GRFSALK INST FOR BIOLOGICAL STUDI·Filed 1983·Granted Apr 29, 1986·23 cites·10 claims
- 2169US4902782AIsolation of fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1988·Granted Feb 20, 1990·26 cites·10 claims
- 2267US5464774ABovine basic fibroblast growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1987·Granted Nov 7, 1995·31 cites·3 claims
- 2365US7371574B2Antibody antagonists of VE-cadherin without adverse effects on vascular permeabilityIMCLONE SYSTEMS INC·Filed 2002·Granted May 13, 2008·2 cites·11 claims
- 2464US5563130AMethods for inhibiting angiogenesis, proliferation of endothelial or tumor cells and tumor growthAMERICAN CYANAMID CO·Filed 1994·Granted Oct 8, 1996·28 cites·5 claims
- 2564US4605643AOvine GRFSALK INST FOR BIOLOGICAL STUDI·Filed 1984·Granted Aug 12, 1986·19 cites·12 claims
- 2662US5210026AHuman mk gene and method of expressionAMERICAN CYANAMID CO·Filed 1991·Granted May 11, 1993·25 cites·14 claims
- 2762US4675383APurification of T-cell growth factorSALK INST FOR BIOLOGICAL STUDI·Filed 1984·Granted Jun 23, 1987·20 cites·19 claims
- 2861US5641743ATherapeutic compositions and methods for use of heparin-binding brain mitogensAMERICAN CYANAMID CO·Filed 1995·Granted Jun 24, 1997·14 cites·6 claims
- 2961US2008311121A1Antibody antagonists of ve-cadherin without adverse effects on vascular permeabilityIMCLONE SYSTEMS INC·Filed 2008·Application pending·0 cites
- 3061US2008317750A1Antibody antagonists of ve-cadherin without adverse effects on vascular permeabilityIMCLONE SYSTEMS INC·Filed 2008·Application pending·0 cites
- 3161US2009060909A1Antibody antagonists of ve-cadherin without adverse effects on vascular permeabilityIMCLONE SYSTEMS INC·Filed 2008·Application pending·0 cites
- 3243US5206354ADna sequence encoding active fragment of fibroblast growth factor, hbf-2AMERICAN CYANAMID CO·Filed 1990·Granted Apr 27, 1993·7 cites·3 claims
- 3342US2004247577A1Method and composition for inhibiting heparanase activityFiled 2002·Application pending·0 cites
- 3434US6511823B1Heparin binding neurotrophic factor gene sequenceAMERICAN CYANAMID CO·Filed 1990·Granted Jan 28, 2003·2 cites·12 claims
- 3534US5171842AHeparin-binding brain mitogensAMERICAN CYANAMID CO·Filed 1991·Granted Dec 15, 1992·5 cites·3 claims
- 3631US5270449AMethods for the isolation of heparin-binding brain mitogensAMERICAN CYANAMID CO·Filed 1992·Granted Dec 14, 1993·3 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Peter Bohlen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →